- Home
- PHUN vs GNTA Comparison
PHUN vs GNTA Comparison
Compare PHUN & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHUN
- GNTA
- Stock Information
- Founded
- PHUN 2009
- GNTA 2014
- Country
- PHUN United States
- GNTA Italy
- Employees
- PHUN N/A
- GNTA N/A
- Industry
- PHUN EDP Services
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PHUN Technology
- GNTA Health Care
- Exchange
- PHUN Nasdaq
- GNTA Nasdaq
- Market Cap
- PHUN 64.1M
- GNTA 70.6M
- IPO Year
- PHUN N/A
- GNTA 2021
- Fundamental
- Price
- PHUN $2.64
- GNTA $3.78
- Analyst Decision
- PHUN Buy
- GNTA Strong Buy
- Analyst Count
- PHUN 2
- GNTA 1
- Target Price
- PHUN $7.75
- GNTA $25.00
- AVG Volume (30 Days)
- PHUN 375.1K
- GNTA 4.7K
- Earning Date
- PHUN 08-15-2025
- GNTA 01-01-0001
- Dividend Yield
- PHUN N/A
- GNTA N/A
- EPS Growth
- PHUN N/A
- GNTA N/A
- EPS
- PHUN N/A
- GNTA N/A
- Revenue
- PHUN $2,956,000.00
- GNTA N/A
- Revenue This Year
- PHUN $3.01
- GNTA N/A
- Revenue Next Year
- PHUN $50.72
- GNTA N/A
- P/E Ratio
- PHUN N/A
- GNTA N/A
- Revenue Growth
- PHUN N/A
- GNTA N/A
- 52 Week Low
- PHUN $2.22
- GNTA $2.74
- 52 Week High
- PHUN $14.60
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- PHUN 35.17
- GNTA 50.34
- Support Level
- PHUN $2.62
- GNTA $3.70
- Resistance Level
- PHUN $3.36
- GNTA $3.84
- Average True Range (ATR)
- PHUN 0.19
- GNTA 0.14
- MACD
- PHUN -0.07
- GNTA -0.00
- Stochastic Oscillator
- PHUN 8.33
- GNTA 30.77
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.